World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01007422
Date of registration: 03/11/2009
Primary sponsor: Vanderbilt-Ingram Cancer Center
Public title: Studying Different Doses of Opioids in Hospice Patients With Cancer-Related Pain
Scientific title: Opioid Titration In the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol Stage 2, Part B
Date of first enrolment: June 2008
Target sample size: 0
Recruitment status: Withdrawn
URL:  http://clinicaltrials.gov/show/NCT01007422
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Countries of recruitment
Contacts
Name:   Barbara A. Murphy, MD
Address: 
Telephone:
Email:
Affiliation:  Vanderbilt-Ingram Cancer Center
Key inclusion & exclusion criteria

DISEASE CHARACTERISTICS:

- Meets 1 of the following criteria:

- Outpatient at the Alive Hospice in the State of Tennessee

- Diagnosed with carcinoma

- Pain requiring fixed-dose opioids

- Caregiver for an Alive Hospice patient

- Any caregiver who is identified by the patient is eligible

PATIENT CHARACTERISTICS:

- Not pregnant or nursing

- Able to speak/comprehend English

- Lives within a 60-mile radius of Alive Hospice

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics



Age minimum: 21 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Pain
Solid Tumor
Intervention(s)
Behavioral: telephone-based intervention
Other: communication intervention
Other: intervention by caregiver
Other: medical chart review
Other: questionnaire administration
Other: survey administration
Procedure: end-of-life treatment/management
Procedure: pain therapy
Procedure: psychosocial assessment and care
Primary Outcome(s)
Safety and feasibility of an oral opioid-titration order sheet in the hospice setting [Time Frame: Yes]
Secondary Outcome(s)
Secondary ID(s)
P30CA068485
VICC-SUPP-0822
VU-VICC-IRB-IRB-080370
VU-VICC-SUPP-0822
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Cancer Institute (NCI)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history